- Home
- SLRN vs ZH Comparison
SLRN vs ZH Comparison
Compare SLRN & ZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRN
- ZH
- Stock Information
- Founded
- SLRN 2020
- ZH 2011
- Country
- SLRN United States
- ZH China
- Employees
- SLRN N/A
- ZH N/A
- Industry
- SLRN Biotechnology: Pharmaceutical Preparations
- ZH Business Services
- Sector
- SLRN Health Care
- ZH Consumer Discretionary
- Exchange
- SLRN Nasdaq
- ZH Nasdaq
- Market Cap
- SLRN 309.0M
- ZH 304.3M
- IPO Year
- SLRN 2023
- ZH 2021
- Fundamental
- Price
- SLRN $1.99
- ZH $3.47
- Analyst Decision
- SLRN Hold
- ZH Strong Buy
- Analyst Count
- SLRN 5
- ZH 2
- Target Price
- SLRN $9.60
- ZH $5.65
- AVG Volume (30 Days)
- SLRN 1.6M
- ZH 189.0K
- Earning Date
- SLRN 11-13-2024
- ZH 11-26-2024
- Dividend Yield
- SLRN N/A
- ZH N/A
- EPS Growth
- SLRN N/A
- ZH N/A
- EPS
- SLRN N/A
- ZH N/A
- Revenue
- SLRN N/A
- ZH $552,853,374.00
- Revenue This Year
- SLRN N/A
- ZH N/A
- Revenue Next Year
- SLRN N/A
- ZH $8.26
- P/E Ratio
- SLRN N/A
- ZH N/A
- Revenue Growth
- SLRN N/A
- ZH N/A
- 52 Week Low
- SLRN $1.91
- ZH $2.55
- 52 Week High
- SLRN $8.89
- ZH $5.28
- Technical
- Relative Strength Index (RSI)
- SLRN 27.77
- ZH 48.95
- Support Level
- SLRN $1.96
- ZH $3.19
- Resistance Level
- SLRN $2.19
- ZH $3.50
- Average True Range (ATR)
- SLRN 0.25
- ZH 0.15
- MACD
- SLRN -0.03
- ZH -0.01
- Stochastic Oscillator
- SLRN 3.92
- ZH 43.08
About SLRN ACELYRIN INC.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of of transformative medicines.
About ZH Zhihu Inc. (every two of each representing one ordinary share)
Zhihu Inc is predominantly engaged in the operation of one online content community and monetizes through paid membership services, advertising services, content-commerce solutions services, and vocational training in China. It generates revenues from Advertising services, Paid membership services, Content-commerce solutions, and Others. It derives all its revenues within China.